These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
29. Measurement of liver stiffness with two imaging techniques: magnetic resonance elastography and ultrasound elastometry. Bensamoun SF; Wang L; Robert L; Charleux F; Latrive JP; Ho Ba Tho MC J Magn Reson Imaging; 2008 Nov; 28(5):1287-92. PubMed ID: 18972339 [TBL] [Abstract][Full Text] [Related]
30. Noninvasive assessment of liver fibrosis by measurement of stiffness in patients with nonalcoholic fatty liver disease (NAFLD). Yoneda M; Yoneda M; Mawatari H; Fujita K; Endo H; Iida H; Nozaki Y; Yonemitsu K; Higurashi T; Takahashi H; Kobayashi N; Kirikoshi H; Abe Y; Inamori M; Kubota K; Saito S; Tamano M; Hiraishi H; Maeyama S; Yamaguchi N; Togo S; Nakajima A Dig Liver Dis; 2008 May; 40(5):371-8. PubMed ID: 18083083 [TBL] [Abstract][Full Text] [Related]
31. Comparison of transient elastography and liver biopsy for the assessment of liver fibrosis in HIV/hepatitis C virus-coinfected patients and correlation with noninvasive serum markers. Sánchez-Conde M; Montes-Ramírez ML; Miralles P; Alvarez JM; Bellón JM; Ramírez M; Arribas JR; Gutiérrez I; López JC; Cosín J; Alvarez E; González J; Berenguer J J Viral Hepat; 2010 Apr; 17(4):280-6. PubMed ID: 19732322 [TBL] [Abstract][Full Text] [Related]
32. Assessment of liver fibrosis and steatosis in PBC with FibroScan, MRI, MR-spectroscopy, and serum markers. Friedrich-Rust M; Müller C; Winckler A; Kriener S; Herrmann E; Holtmeier J; Poynard T; Vogl TJ; Zeuzem S; Hammerstingl R; Sarrazin C J Clin Gastroenterol; 2010 Jan; 44(1):58-65. PubMed ID: 19581812 [TBL] [Abstract][Full Text] [Related]
33. Transient elastography: a new surrogate marker of liver fibrosis influenced by major changes of transaminases. Coco B; Oliveri F; Maina AM; Ciccorossi P; Sacco R; Colombatto P; Bonino F; Brunetto MR J Viral Hepat; 2007 May; 14(5):360-9. PubMed ID: 17439526 [TBL] [Abstract][Full Text] [Related]
34. [Non-invasive diagnosis of liver fibrosis: guidelines for the use of biomarkers and FibroScan]. Vergniol J; de Ledinghen V Gastroenterol Clin Biol; 2009 Apr; 33(4):334-44. PubMed ID: 19346090 [No Abstract] [Full Text] [Related]
35. Transient elastography in the assessment of liver fibrosis in adult thalassemia patients. Fraquelli M; Cassinerio E; Roghi A; Rigamonti C; Casazza G; Colombo M; Massironi S; Conte D; Cappellini MD Am J Hematol; 2010 Aug; 85(8):564-8. PubMed ID: 20658587 [TBL] [Abstract][Full Text] [Related]
36. Technology Insight: noninvasive assessment of liver fibrosis by biochemical scores and elastography. Pinzani M; Vizzutti F; Arena U; Marra F Nat Clin Pract Gastroenterol Hepatol; 2008 Feb; 5(2):95-106. PubMed ID: 18253138 [TBL] [Abstract][Full Text] [Related]
39. Transient elastography: a valid alternative to biopsy in patients with chronic liver disease. Gómez-Domínguez E; Mendoza J; Rubio S; Moreno-Monteagudo JA; García-Buey L; Moreno-Otero R Aliment Pharmacol Ther; 2006 Aug; 24(3):513-8. PubMed ID: 16886917 [TBL] [Abstract][Full Text] [Related]
40. Development of a non-invasive algorithm with transient elastography (Fibroscan) and serum test formula for advanced liver fibrosis in chronic hepatitis B. Wong GL; Wong VW; Choi PC; Chan AW; Chan HL Aliment Pharmacol Ther; 2010 May; 31(10):1095-103. PubMed ID: 20180785 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]